CINC

CinCor Pharma, Inc. Common Stock
CINC

Delisted

CINC was delisted on the 23rd of February, 2023.

Back to rankings

53 hedge funds and large institutions have $520M invested in CinCor Pharma, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$97.8M
2
+$76.1M
3
+$72.4M
4
PA
Perceptive Advisors
New York
+$40.7M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$36.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$533K
27
$496K
28
$387K
29
$284K
30
$262K
31
$238K
32
$210K
33
$167K
34
$163K
35
$142K
36
$120K
37
$101K
38
$95K
39
$87K
40
$53K
41
$47K
42
$44K
43
$40K
44
$40K
45
$38K
46
$34K
47
$32K
48
$19K
49
$18K
50
$18K
1
2
3